Insiders · Profile

Semba Charles Pauling

Director at DiaMedica Therapeutics. Filing since 23 Jun 2023. CIK 0001872863

Company

Date

Role

Action

Shares

Amount

Of holding

DMAC DiaMedica Therapeutics Inc.

23 Jun 2023

Director

Bought

12,787

$50.00K

74.5%

1 decision on file.